Australia markets closed

SciClone Pharmaceuticals (Holdings) Limited (6600.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
18.260+0.020 (+0.11%)
At close: 04:08PM HKT
Currency in HKD

Valuation measures4

Market cap (intra-day) 11.45B
Enterprise value 9.08B
Trailing P/E 9.82
Forward P/E 7.04
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.48
Price/book (mrq)3.24
Enterprise value/revenue 2.66
Enterprise value/EBITDA 5.91

Trading information

Stock price history

Beta (5Y monthly) 0.77
52-week change 362.86%
S&P500 52-week change 326.36%
52-week high 318.340
52-week low 38.750
50-day moving average 316.787
200-day moving average 312.618

Share statistics

Avg vol (3-month) 34.59M
Avg vol (10-day) 32.83M
Shares outstanding 5626.97M
Implied shares outstanding 6626.97M
Float 8309.61M
% held by insiders 140.75%
% held by institutions 120.09%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.39
Forward annual dividend yield 42.14%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 420.49%
Dividend date 3N/A
Ex-dividend date 402 June 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 35.55%
Operating margin (ttm)39.01%

Management effectiveness

Return on assets (ttm)20.40%
Return on equity (ttm)35.86%

Income statement

Revenue (ttm)3.16B
Revenue per share (ttm)5.13
Quarterly revenue growth (yoy)21.80%
Gross profit (ttm)N/A
EBITDA 1.49B
Net income avi to common (ttm)1.12B
Diluted EPS (ttm)1.860
Quarterly earnings growth (yoy)52.20%

Balance sheet

Total cash (mrq)2.22B
Total cash per share (mrq)3.68
Total debt (mrq)32.83M
Total debt/equity (mrq)1.01%
Current ratio (mrq)4.94
Book value per share (mrq)5.41

Cash flow statement

Operating cash flow (ttm)1.4B
Levered free cash flow (ttm)906.46M